This article has been updated with information from Hologic's earnings presentation.

NEW YORK (GenomeWeb) – Hologic reported after the close of the market Wednesday that revenues for its first quarter of fiscal year 2017 were up around 6 percent year over year, driven in part by strong growth in molecular diagnostics product revenues. 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.